Results 21 to 30 of about 77,953 (304)

Evaluation of a New Chemiluminescent Immunoassay-Based Interferon-Gamma Release Assay for Detection of Latent Tuberculosis Infection

Medicina, 2023
Background and Objectives: This study aimed to evaluate the performance of a new chemiluminescent immunoassay-based tuberculosis (TB) interferon-gamma release assay (IGRA), AdvanSureI3 TB-IGRA (LG Chem Ltd., Seoul, Republic of Korea), for detecting ...
Keun Ju Kim, Seong-Eun Ryu, Ha-Na Lee, Seung-Hwan Oh, Chulhun L. Chang   +4 more
doaj   +1 more source

Development and evaluation of a diagnostic cytokine-release assay for Mycobacterium suricattae infection in meerkats (Suricata suricatta) [PDF]

, 2017
CITATION: Clarke, C., et al. 2017. Development and evaluation of a diagnostic cytokine-release assay for mycobacterium suricattae infection in meerkats (Suricata suricatta).
A Dippenaar, C Clarke, Charlene Clarke, I Schiller, JA Drewe, JA Drewe, JA Drewe, Julian Ashley Drewe, KA Millington, KE Bass, M Ruhwald, Michele Ann Miller, MP Petticrew, NN Chegou, Paul David van Helden, R Rua-Domenech de la, SDC Parsons, SDC Parsons, Stuart James Patterson, Sven David Charles Parsons, TH Clutton-Brock, WJ Goosen, WJ Goosen   +22 more
core   +3 more sources

Implementation of routine interferon-gamma release assay testing in a South London HIV cohort [PDF]

International Journal of STD & AIDS, 2020
Human immunodeficiency virus (HIV) infection is a major risk factor for the development of tuberculosis (TB). Although guidelines recommend that people with HIV from high TB incidence countries and those with risk factors are screened for latent TB infection (LTBI) using interferon-gamma release assays (IGRAs), this has not been widely implemented in ...
Preeti Sandhu, Chris Taylor, Robert F Miller, Frank A Post   +3 more
openaire   +4 more sources

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India [PDF]

Intestinal Research, 2018
Background/Aims The data on the risk of tuberculosis (TB) reactivation with infliximab (IFX) in patients with inflammatory bowel disease (IBD) from TB endemic countries, like India, is limited.
Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja   +10 more
doaj   +1 more source

Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities [PDF]

, 2012
Tuberculosis is unique among the major infectious diseases in that it lacks accurate rapid point-of-care diagnostic tests. Failure to control the spread of tuberculosis is largely due to our inability to detect and treat all infectious cases of pulmonary
Alexandre Harari, Alimuddin Zumla, Armand, Axelsson-Robertson, Banada, Ben Marais, Betsou, Blakemore, Boehme, Boehme, Cattamanchi, Chow, Cuevas, Cuevas, Cuevas, Cuevas, Diel, Dowdy, Dye, European Centre for Disease Prevention and Control, Ferrara, Giovanni-Batista Migliori, Giuseppe Pantaleo, Green, Harari, Helb, Helen Cox, Hillemann, Hohn, Ibrahim Abubakar, Jeremiah Chakaya, John, Justin O’Grady, Karin Weyer, Keeler, Kemp, Kunnath-Velayudhan, Lawn, Lawn, Lawn, Lawn, Lawn, Lemaire, Lin, Ling, Liu, Long, Lucica Ditui, Lynn Zijenah, Mann, Marais, Marais, Marais, Marais, Marco Schito, Markus Maeurer, Marlowe, Martin P. Grobusch, Martina Casenghi, Matthew Bates, McNerney, Michael Hoelscher, Michel Pletschette, Minion, Moore, Morris, Mwaba, Nathan Ford, Nathanson, National Institute for Health and Clinical Excellence, Nicol, Nicol, Oberhelman, O’Grady, Peter, Peter Mwaba, Peter S. Kim, Rifat Atun, Rose, Ruth McNerney, S. Bertel Squire, Samana Schwank, Sester, Shah, Soumya Swaminathan, Squire, Squire, Steingart, Steingart, Steingart, Steve Lawn, Storla, Temple, Theron, Timothy D. Mchugh, Treatment Action Group, Tully, Vadwai, Van Rie, van Wyk, Wallis, Walzl, Weyer, Wilson, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, Wright, Wright, Zar, Ziad Memish, Zumla, Zumla   +118 more
core   +2 more sources

Testing for Tuberculosis: The Roles of Tuberculin Skin Tests and Interferon Gamma Release Assays [PDF]

Laboratory Medicine, 2011
The identification of latent tuberculosis infection (LTBI) in any individual or population has proven to carry significant importance not only for that person’s health, but also for the control and eventual elimination of tuberculosis (TB) in the United States.
Alessandra Regatieri, Yehia Abdelwahed, Maria T. Perez, Larry M. Bush   +3 more
openaire   +1 more source

Tuberculosis in Children: New diagnostic Blood Tests

Canadian Journal of Infectious Diseases and Medical Microbiology, 2010
The interferon-gamma-release assays were developed to overcome the pitfalls and logistic difficulties of the tuberculin skin test (TST) for the diagnosis of latent tuberculosis infection (LTBI).
F Kakkar, UD Allen, D Ling, M Pai, IC Kitai   +4 more
doaj   +1 more source

Screening for Tuberculosis in Health Care Workers. Experience in an Italian Teaching Hospital [PDF]

, 2017
Health care workers (HCW) are particularly at risk of acquiring tuberculosis (TB), even in countries with low TB incidence. Therefore, TB screening in HCW is a useful prevention strategy in countries with both low and high TB incidence.
De Luca, Assunta, DI NINNO, Filippo, Ferretti, Filippo, Marani, Alessandra, Napoli, Christian, Orioli, Riccardo, Orsi, Giovanni Battista, Prestigiacomo, Claudio, Sarlo, MARIA GIUDITTA   +8 more
core   +3 more sources

Interferon-gamma-release assays: Better than tuberculin skin testing?

Cleveland Clinic Journal of Medicine, 2010
Although the tuberculin skin test has long been the standard for detecting latent tuberculosis infection, it has many limitations. Interferon-gamma-release assays are gaining acceptance as an alternative. In this paper we present cases to illustrate how these new tests can be used and how to interpret the results.
Cyndee, Miranda, J Walton, Tomford, Steven M, Gordon   +2 more
openaire   +2 more sources

Agreement between the results of tuberculin skin test and Interferon-Gamma Release Assays in renal transplant candidates

Journal of Research in Medical Sciences, 2021
Introduction: Identification of latent tuberculosis (TB) infection is important in kidney transplant candidates. Due to the absence of a gold standard, both tuberculin skin test (TST) and interferon-gamma release assays (IGRA) are used to screen patients.
Shiva Samavat, Sam Alahyari, Ali Sangian, Malihe Nasiri, Mohsen Nafar, Ahmad Firoozan, Fariba Samadian, Nooshin Dalili, Fatemeh Poorrezagholi   +8 more
doaj   +1 more source